scholarly article | Q13442814 |
meta-analysis | Q815382 |
P6179 | Dimensions Publication ID | 1032175787 |
P356 | DOI | 10.1007/S00125-014-3260-6 |
P698 | PubMed publication ID | 24859435 |
P50 | author | Sanne A Peters | Q57419936 |
Rachel Huxley | Q73905345 | ||
P2093 | author name string | Mark Woodward | |
P2860 | cites work | ??? | Q57267237 |
Prevalence of diabetes mellitus and population attributable fractions for coronary heart disease and stroke mortality in the WHO South-East Asia and Western Pacific regions. | Q55042924 | ||
Women develop type 2 diabetes at a higher body mass index than men | Q57274484 | ||
Cohort profile: the Asia Pacific Cohort Studies Collaboration | Q57583286 | ||
Mortality among diabetics in a national sample | Q68444875 | ||
UK Prospective Diabetes Study. IV. Characteristics of newly presenting type 2 diabetic patients: male preponderance and obesity at different ages. Multi-center Study | Q70049487 | ||
Risk factors for coronary heart disease in the prospective Dubbo Study of Australian elderly | Q70860135 | ||
Oxidized lipids in insulin-dependent diabetes mellitus: a sex-diabetes interaction? | Q72184372 | ||
Risk factors for coronary heart disease among older men and women: a prospective study of community-dwelling elderly | Q72671601 | ||
Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures | Q72843738 | ||
Type II diabetes abrogates sex differences in endothelial function in premenopausal women | Q73734948 | ||
Abnormal glucose regulation and gender-specific risk of fatal coronary artery disease in the HUNT 1 study | Q83390469 | ||
Measuring inconsistency in meta-analyses | Q27860655 | ||
Quantifying heterogeneity in a meta-analysis | Q27860672 | ||
Sex disparities in treatment of cardiac risk factors in patients with type 2 diabetes | Q28218237 | ||
The Atherosclerosis Risk in Communities (ARIC) Study: design and objectives. The ARIC investigators | Q29614947 | ||
Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones. | Q30619788 | ||
Excess risk of fatal coronary heart disease associated with diabetes in men and women: meta-analysis of 37 prospective cohort studies. | Q34251047 | ||
Do men develop type 2 diabetes at lower body mass indices than women? | Q34454220 | ||
The metabolic syndrome and the impact of diabetes on coronary heart disease mortality in women and men: the San Antonio Heart Study | Q34581473 | ||
Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis | Q34769943 | ||
Adding social deprivation and family history to cardiovascular risk assessment: the ASSIGN score from the Scottish Heart Health Extended Cohort (SHHEC) | Q35773156 | ||
Gender disparities in diabetes and coronary heart disease medication among patients with type 2 diabetes: results from the DIANA study | Q36478621 | ||
Self-reported diabetes mellitus and risk of mortality from all causes, cardiovascular disease, and cancer in Takayama: a population-based prospective cohort study in Japan | Q36632050 | ||
Sex disparities in the treatment and control of cardiovascular risk factors in type 2 diabetes | Q36756713 | ||
The fraction of ischaemic heart disease and stroke attributable to smoking in the WHO Western Pacific and South-East Asian regions. | Q36930328 | ||
The impact of diabetes on coronary heart disease differs from that on ischaemic stroke with regard to the gender | Q37185919 | ||
Sex and racial/ethnic differences in cardiovascular disease risk factor treatment and control among individuals with diabetes in the Multi-Ethnic Study of Atherosclerosis (MESA) | Q37269405 | ||
Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies | Q37916895 | ||
Smoking as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 81 cohorts, including 3,980,359 individuals and 42,401 strokes. | Q38130929 | ||
Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775,385 individuals and 12,539 strokes. | Q38194709 | ||
Impact of glucose tolerance status on development of ischemic stroke and coronary heart disease in a general Japanese population: the Hisayama study | Q43235322 | ||
Sex differences in risk for coronary heart disease mortality associated with diabetes and established coronary heart disease | Q43766844 | ||
Do lipids, blood pressure, diabetes, and smoking confer equal risk of myocardial infarction in women as in men? The Reykjavik Study. | Q43990384 | ||
Influence of type 2 diabetes mellitus on cardiovascular disease mortality: findings from the Hawaii-Los Angeles-Hiroshima study | Q43990996 | ||
Mortality rates and risk factors for coronary disease in black as compared with white men and women | Q44997158 | ||
Women show worse control of type 2 diabetes and cardiovascular disease risk factors than men: results from the MIND.IT Study Group of the Italian Society of Diabetology. | Q45809719 | ||
Effects of traditional coronary risk factors on rates of incident coronary events in a low-risk population. The Adventist Health Study | Q46206394 | ||
Sex disparities in control and treatment of modifiable cardiovascular disease risk factors among patients with diabetes: Translating Research Into Action for Diabetes (TRIAD) Study | Q46216750 | ||
Sex differences in cardiovascular and total mortality among diabetic and non-diabetic individuals with or without history of myocardial infarction | Q46435672 | ||
Should diabetes be considered a coronary heart disease risk equivalent?: results from 25 years of follow-up in the Renfrew and Paisley survey | Q46570693 | ||
Adverse effects of diabetes on multiple cardiovascular disease risk factors in women. The Strong Heart Study | Q47693461 | ||
Low educational status is a risk factor for mortality among diabetic people | Q50110902 | ||
Sex differences in coagulation and fibrinolysis in subjects with coronary artery disease. | Q50892030 | ||
Relatively more atherogenic coronary heart disease risk factors in prediabetic women than in prediabetic men. | Q50946808 | ||
Sex differences in coagulation and fibrinolysis in white subjects with non-insulin-dependent diabetes mellitus. | Q51044900 | ||
Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. | Q51252378 | ||
Do women exhibit greater differences in established and novel risk factors between diabetes and non-diabetes than men? The British Regional Heart Study and British Women's Heart Health Study. | Q51369167 | ||
Sex differences in endothelial function markers before conversion to pre-diabetes: does the clock start ticking earlier among women? The Western New York Study. | Q51479725 | ||
Non-insulin-dependent diabetes and 11-year mortality in Asian Indian and Melanesian Fijians. | Q51582992 | ||
The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region. | Q51689150 | ||
Prediction of coronary heart disease in a population with high prevalence of diabetes and albuminuria: the Strong Heart Study. | Q51939995 | ||
Influence of patient sex and gender on medication use, adherence, and prescribing alignment with guidelines. | Q54637578 | ||
P433 | issue | 8 | |
P921 | main subject | heart disease | Q190805 |
meta-analysis | Q815382 | ||
coronary artery disease | Q844935 | ||
risk factor | Q1475848 | ||
systematic review | Q1504425 | ||
P304 | page(s) | 1542-1551 | |
P577 | publication date | 2014-05-25 | |
P1433 | published in | Diabetologia | Q5270140 |
P1476 | title | Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events | |
P478 | volume | 57 |
Q90549493 | "H" for Heterogeneity in the Algorithm for Type 2 Diabetes Management |
Q64076629 | A Sex-Specific Analysis of the Predictive Value of Troponin I and T in Patients With and Without Diabetes Mellitus After Successful Coronary Intervention |
Q38852088 | Acute coronary syndromes in women and men. |
Q87197561 | Acute coronary syndromes: Acute MI in women--the fountain of youth has run dry |
Q91673027 | Adverse differences in cardiometabolic risk factor levels between individuals with pre-diabetes and normal glucose metabolism are more pronounced in women than in men: the Maastricht Study |
Q39317314 | Assessing and Modifying Coronary Artery Disease Risk in Women |
Q39004037 | Association Between Diabetes and Cause-Specific Mortality in Rural and Urban Areas of China |
Q48163821 | Association between body mass index and obesity-related cancer risk in men and women with type 2 diabetes in primary care in the Netherlands: a cohort study (ZODIAC-56). |
Q92000090 | Association between diabetes mellitus and the risk for major cardiovascular outcomes and all-cause mortality in women compared with men: a meta-analysis of prospective cohort studies |
Q64241793 | Association of Diabetes Mellitus Status and Glycemic Control With Secondary Prevention Medication Adherence After Acute Myocardial Infarction |
Q64100807 | Association of Diabetes With All-Cause and Cause-Specific Mortality in Asia: A Pooled Analysis of More Than 1 Million Participants |
Q90536360 | Association of smoking with coronary artery disease in Nepalese populations: a case control study |
Q35044626 | Asymptomatic diabetes: screening by routine imaging beneficial? |
Q26770901 | Atrial fibrillation as risk factor for cardiovascular disease and death in women compared with men: systematic review and meta-analysis of cohort studies |
Q64093512 | Cardiovascular Disease and the Female Disadvantage |
Q89873881 | Cardiovascular Disease in Women Across the Lifespan: The Importance of Sleep |
Q39420208 | Cardiovascular disease prevention strategies for type 2 diabetes mellitus |
Q92545435 | Cardiovascular risk reduction with once-weekly semaglutide in subjects with type 2 diabetes: a post hoc analysis of gender, age, and baseline CV risk profile in the SUSTAIN 6 trial |
Q37726992 | Change in lifestyle behaviors and diabetes risk: evidence from a population-based cohort study with 10 year follow-up |
Q34323479 | Combined effects of admission serum creatinine concentration with age and gender on the prognostic significance of subjects with acute ST-elevation myocardial infarction in China |
Q64259297 | Coronary Heart Disease and ABO Blood Group in Diabetic Women: A Case-Control Study |
Q64102066 | Coronary Heart Disease and Dietary Carbohydrate, Glycemic Index, and Glycemic Load: Dose-Response Meta-analyses of Prospective Cohort Studies |
Q93353860 | Coronary Microvascular Disease Pathogenic Mechanisms and Therapeutic Options: JACC State-of-the-Art Review |
Q91840038 | Demographic and Clinical Factors Associated with Development of Type 2 Diabetes: A Review of the Literature |
Q88645122 | Diabetes and cardiovascular mortality: the impact of sex |
Q41463751 | Diabetes and ischemic heart disease death in people age 25-54: a multiple-cause-of-death analysis based on over 400 000 deaths from 1990 to 2008 in New York City. |
Q41363042 | Diabetes and the female disadvantage. |
Q91977335 | Diabetes as a risk factor for heart failure in women and men: a systematic review and meta-analysis of 47 cohorts including 12 million individuals |
Q99710691 | Diabetes mellitus is associated with a higher risk for major depressive disorder in women than in men |
Q97528620 | Diabetes, Glycated Hemoglobin, and the Risk of Myocardial Infarction in Women and Men: A Prospective Cohort Study of the UK Biobank |
Q64953921 | DiabetesSistersVoices: Virtual Patient Community to Identify Research Priorities for Women Living With Diabetes. |
Q55222687 | Diabetic Cardiomyopathy: Impact of Biological Sex on Disease Development and Molecular Signatures. |
Q35573204 | Diagnosed diabetes and premature death among middle-aged Japanese: results from a large-scale population-based cohort study in Japan (JPHC study). |
Q92152159 | Different physiological mechanisms underlie an adverse cardiovascular disease risk profile in men and women |
Q33733996 | Does Gender Influence the Cardiovascular Benefits Observed with Sodium Glucose Co-Transporter-2 (SGLT-2) Inhibitors? A Meta-Regression Analysis. |
Q46730696 | Earlier onset of diabesity-Induced adverse cardiac remodeling in female compared to male mice |
Q93384115 | Effectiveness of plant-based diets in promoting well-being in the management of type 2 diabetes: a systematic review |
Q96228404 | Effects of Spirulina platensis on insulin secretion, DPP-IV activity and both carbohydrate digestion and absorption indicate potential as an adjunctive therapy for diabetes |
Q64977737 | Effects of lifestyle-related factors on ischemic heart disease according to body mass index and fasting blood glucose levels in Korean adults. |
Q58624033 | Elevated fasting blood glucose, but not obesity, is associated with coronary artery disease in patients undergoing elective coronary angiography in a referral hospital in Jordan |
Q97520305 | Endothelial Dysfunction and Passive Changes in the Aorta and Coronary Arteries of Diabetic db/db Mice |
Q30388554 | Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications |
Q46627262 | Evaluation of the efficacy, safety and glycaemic effects of evolocumab (AMG 145) in hypercholesterolaemic patients stratified by glycaemic status and metabolic syndrome. |
Q35533775 | Excess cardiovascular risk in diabetic women: a case for intensive treatment |
Q40086333 | Excess psychosocial burden in women with diabetes and premature acute coronary syndrome. |
Q35939395 | Exploring the impact of chronic obstructive pulmonary disease (COPD) on diabetes control in diabetes patients: a prospective observational study in general practice |
Q52562168 | Female reproductive history and risk of type 2 diabetes: a prospective analysis of 126,721 women. |
Q92844048 | Female-friendly focus: 2019 ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease |
Q49224100 | Gender Difference in the Association of Early- vs. Late-Onset Type 2 Diabetes with Non-Fatal Microvascular Disease in China: A Cross-sectional Study |
Q42281490 | Gender Disparities in Lipid Goal Attainment among Type 2 Diabetes Outpatients with Coronary Heart Disease: Results from the CCMR-3B Study |
Q41365215 | Gender differences in hospital admissions for major cardiovascular events and procedures in people with and without diabetes in England: a nationwide study 2004-2014. |
Q40571078 | Gender differences in the relationship between diabetes process of care indicators and cardiovascular outcomes |
Q38620945 | Gliptin therapy reduces hepatic and myocardial fat in type 2 diabetic patients Gliptins and cardiometabolic risk |
Q90355905 | Glycaemic control and excess risk of major coronary events in patients with type 2 diabetes: a population-based study |
Q38642356 | Health and economic benefits of reducing sugar intake in the USA, including effects via non-alcoholic fatty liver disease: a microsimulation model |
Q47666087 | Incident diabetes mellitus may explain the association between sleep duration and incident coronary heart disease. |
Q58362346 | Japan Atherosclerosis Society (JAS) Guidelines for Prevention of Atherosclerotic Cardiovascular Diseases 2017 |
Q91786606 | Karma of Cardiovascular Disease Risk Factors for Prevention and Management of Major Cardiovascular Events in the Context of Acute Exacerbations of Chronic Obstructive Pulmonary Disease |
Q51734047 | Lipid Effects of Icosapent Ethyl in Women with Diabetes Mellitus and Persistent High Triglycerides on Statin Treatment: ANCHOR Trial Subanalysis. |
Q50254498 | Measurement of glycated albumin in serum and plasma by LC-MS/MS. |
Q47266809 | Meat intake and incidence of cardiovascular disease in Japanese patients with type 2 diabetes: analysis of the Japan Diabetes Complications Study (JDCS). |
Q42202570 | Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort |
Q26770233 | Microvesicles and exosomes: new players in metabolic and cardiovascular disease |
Q99566197 | Novel insights into clinical characteristics and in-hospital outcomes of patients undergoing percutaneous coronary intervention in Vietnam |
Q91894841 | PRIMEtime CE: a multistate life table model for estimating the cost-effectiveness of interventions affecting diet and physical activity |
Q90202847 | Population-based cross-sectional study of 11 645 Spanish nonagenarians with type 2 diabetes mellitus: cardiovascular profile, cardiovascular preventive therapies, achievement goals and sex differences |
Q48199112 | Potential of rooibos, its major C-glucosyl flavonoids, and Z-2-(β-D-glucopyranosyloxy)-3-phenylpropenoic acid in prevention of metabolic syndrome |
Q38511034 | Predicting cardiovascular risk in type 2 diabetes: the heterogeneity challenges |
Q64105754 | Prescribing statins among patients with type 2 diabetes: The clinical gap between the guidelines and practice |
Q37499363 | Preventing and Experiencing Ischemic Heart Disease as a Woman: State of the Science: A Scientific Statement From the American Heart Association |
Q64460735 | Prospective Study of Epigenetic Age Acceleration and Incidence of Cardiovascular Disease Outcomes in the ARIC Study (Atherosclerosis Risk in Communities) |
Q61805168 | Protective Effect of Resveratrol against Ischemia-Reperfusion Injury via Enhanced High Energy Compounds and eNOS-SIRT1 Expression in Type 2 Diabetic Female Rat Heart |
Q92351363 | Rationale and tutorial for analysing and reporting sex differences in cardiovascular associations |
Q41648227 | Reducing women's cardiovascular disease risk profile |
Q36820764 | Risk Factors for Cardiovascular Disease in Type 1 Diabetes |
Q33892086 | Risk factors for coronary artery disease in patients undergoing elective coronary angiography in Jordan |
Q64230426 | Risk of all-cause and CHD mortality in women versus men with type 2 diabetes: a systematic review and meta-analysis |
Q36068117 | Risks and Population Burden of Cardiovascular Diseases Associated with Diabetes in China: A Prospective Study of 0.5 Million Adults |
Q41214288 | Salivary flow and xerostomia in older patients with type 2 diabetes mellitus |
Q92419621 | Sex Differences in Cardiovascular Effectiveness of Newer Glucose-Lowering Drugs Added to Metformin in Type 2 Diabetes Mellitus |
Q36044763 | Sex Differences in Diabetes Mellitus Mortality Trends in Brazil, 1980-2012. |
Q91658424 | Sex Differences in Diabetes Prevalence, Comorbidities, and Health Care Utilization among American Indians Living in the Northern Plains |
Q50056771 | Sex Differences in Outcomes after Stroke in Patients with Diabetes in Ontario, Canada. |
Q40352955 | Sex Differences in the Association Between Insulin Resistance and Incident Coronary Heart Disease and Stroke Among Blacks Without Diabetes Mellitus: The Jackson Heart Study |
Q52680886 | Sex Differences in the Association Between Measures of General and Central Adiposity and the Risk of Myocardial Infarction: Results From the UK Biobank. |
Q52578791 | Sex Differences in the Burden and Complications of Diabetes. |
Q90554052 | Sex Differences in the Coronary System |
Q37681936 | Sex Differences in the Effect of Type 2 Diabetes on Major Cardiovascular Diseases: Results from a Population-Based Study in Italy |
Q42537111 | Sex Differences in the Excess Risk of Cardiovascular Diseases Associated with Type 2 Diabetes: Potential Explanations and Clinical Implications |
Q36924868 | Sex Differences in the Renal Function Decline of Patients with Type 2 Diabetes |
Q88398324 | Sex and Gender Differences Research Design for Basic, Clinical, and Population Studies: Essentials for Investigators |
Q28395801 | Sex and Gender Differences in Risk, Pathophysiology and Complications of Type 2 Diabetes Mellitus |
Q98627713 | Sex and gender: modifiers of health, disease, and medicine |
Q28602467 | Sex differences in body anthropometry and composition in individuals with and without diabetes in the UK Biobank |
Q91174561 | Sex differences in cardiometabolic disorders |
Q30234726 | Sex differences in cardiovascular disease - Impact on care and outcomes |
Q92320413 | Sex differences in cardiovascular risk management for people with diabetes in primary care: a cross-sectional study |
Q64893311 | Sex differences in interleukin-6 stress responses in people with Type 2 diabetes. |
Q58593283 | Sex differences in risk factors for myocardial infarction: cohort study of UK Biobank participants |
Q47161295 | Sex differences in survival of patients with type 2 diabetes in primary care (ZODIAC-50). |
Q90356210 | Sex differences in the association between diabetes and cancer: a systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events |
Q91804443 | Sex differences in the association between diabetes and risk of cardiovascular disease, cancer, and all-cause and cause-specific mortality: a systematic review and meta-analysis of 5,162,654 participants |
Q33799803 | Sex differences in the effect of HbA1c-defined diabetes on a wide range of cardiovascular disease risk factors |
Q28084204 | Sex differences in the pathophysiology, treatment, and outcomes in IHD |
Q92405521 | Sex differences in the risk of vascular disease associated with diabetes |
Q40814438 | Sex- and gender-aspects in regard to clinical practice recommendations for pre-diabetes and diabetes |
Q64065776 | Sex-related differences in frailty factors in older persons with type 2 diabetes: a cross-sectional study |
Q33905373 | Sex-specific differential in risk of diabetes-related macrovascular outcomes |
Q92600689 | Standards of medical care for type 2 diabetes in China 2019 |
Q36950782 | Strategies for improving cardiovascular health in women with diabetes mellitus: a review of the evidence |
Q41856851 | Tailoring cardiovascular risk assessment and prevention for women: One size does not fit all. |
Q35795264 | The Effect of Comorbidity on Glycemic Control and Systolic Blood Pressure in Type 2 Diabetes: A Cohort Study with 5 Year Follow-Up in Primary Care |
Q37142656 | The Natural History of Patients With Isolated Metabolic Syndrome |
Q54943208 | The impact of a disease management programme for type 2 diabetes on health-related quality of life: multilevel analysis of a cluster-randomised controlled trial. |
Q41096831 | The impact of gender on the long-term morbidity and mortality of patients with type 2 diabetes receiving structured personal care: a 13 year follow-up study |
Q37635648 | The impact of gender, level of amputation and diabetes on prosthetic fit rates following major lower extremity amputation |
Q38873750 | The influence of social factors on gender health |
Q64057442 | The role of the triglyceride (triacylglycerol) glucose index in the development of cardiovascular events: a retrospective cohort analysis |
Q50985538 | The second myocardial infarction: Higher risk factor burden and earlier second myocardial infarction in women compared with men. The Northern Sweden MONICA study. |
Q35750733 | The sex-specific association between BMI and coronary heart disease: a systematic review and meta-analysis of 95 cohorts with 1·2 million participants |
Q52381478 | The women's heart health programme: a pilot trial of sex-specific cardiovascular management. |
Q30377644 | Translating the WHO 25×25 goals into a UK context: the PROMISE modelling study |
Q64449092 | Trends in incidence and case fatality of acute myocardial infarction, angina and coronary revascularisation in people with and without type 2 diabetes in Scotland between 2006 and 2015 |
Q36490441 | Type 2 Diabetes as a Risk Factor for Dementia in Women Compared With Men: A Pooled Analysis of 2.3 Million People Comprising More Than 100,000 Cases of Dementia |
Q35004093 | Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1·9 million people |
Q30873919 | Use of national data sources in diabetes epidemiology |
Q30376480 | Women's health: a new global agenda. |
Search more.